New decision tool aims to bring palliative care to heart failure patients sooner

NCT ID NCT06933875

Recruiting now Knowledge-focused Sponsor: Yale University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 2 times

Summary

This study tests a clinical decision support tool that helps doctors decide when to refer heart failure patients to palliative care. The tool uses a risk model to predict one-year survival and provides guidance at the point of care. Researchers will enroll 2,260 participants, including healthcare providers and patients, to see if the tool is usable and acceptable. The goal is to improve care that matches patients' goals and needs.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Clinical decision support tool (behavioral intervention)
What this could lead to: If successful, this tool could help doctors identify heart failure patients who would benefit from palliative care earlier, leading to more personalized and goal-aligned care.
What could go wrong: This is a pilot study focused on usability and feasibility, not on patient outcomes. The tool may not change referral rates or improve care in practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE PALLIATIVE CARE

Contacts and locations

Locations

Yale New Haven Hospital Saint Raphael
RECRUITING

New Haven, Connecticut, 06520, United States
Yale New Haven Hospital York Street
RECRUITING

New Haven, Connecticut, 06520, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.